Addus HomeCare Corporation Price & Performance (ADUS)

Addus HomeCare has seen notable increases in institutional ownership, with Bank of Montreal Can boosting its stake by 17.4% in the fourth quarter. Other major investors, such as Principal Financial Group and TimesSquare Capital Management, also expanded their positions, reflecting ongoing confidence in the company's long-term prospects despite recent stock volatility.12

Analysts continue to back Addus HomeCare, reaffirming high price targets and positive ratings. The company’s acquisition of Gentiva’s Personal Care business is expected to add $280 million in annual revenue, and integration efforts are closely watched. Technology initiatives and M&A activity remain central to Addus’s growth strategy.34

Addus HomeCare’s EVP recently sold 178 shares, reducing direct ownership by 1.68%. This move comes after the company missed quarterly earnings estimates, reporting $1.26 EPS versus the expected $1.35. Despite this, the stock maintains a consensus rating of 'Moderate Buy' from analysts, with a $132.78 average price target.56